Bibliographic Citation
| Document | For copies of Journal Articles, please contact the Publisher or your local public or university library and refer to the information in the Resource Relation field. For copies of other documents, please see the Availability, Publisher, Research Organization, Resource Relation and/or Author (affiliation information) fields and/or Document Availability. |
|---|---|
| Title | Palladium-103 versus iodine-125 for ophthalmic plaque radiotherapy |
| Creator/Author | Finger, P.T. (Cornell Univ. Medical College, New York, NY (United States) New York Eye and Ear Infirmary, New York, NY (United States)) ; Lu, D. ; Buffa, A. ; DeBlasio, D.S. ; Bosworth, J.L. (Cornell Univ. Medical College, New York, NY (United States)) |
| Publication Date | 1993 Nov 15 |
| OSTI Identifier | OSTI ID: 7066135 |
| Other Number(s) | Journal ID: ISSN 0360-3016; CODEN: IOBPD3 |
| Resource Type | Journal Article |
| Resource Relation | Journal Name: International Journal of Radiation Oncology, Biology and Physics; (United States); Journal Volume: 27:4 |
| Subject | 63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.; 61 RADIATION PROTECTION AND DOSIMETRY; EYES; MELANOMAS; IODINE 125; SPATIAL DOSE DISTRIBUTIONS; RADIOTHERAPY; PALLADIUM 103; BETA DECAY RADIOISOTOPES; BODY; BODY AREAS; CARCINOMAS; DAYS LIVING RADIOISOTOPES; DISEASES; ELECTRON CAPTURE RADIOISOTOPES; EPITHELIOMAS; EVEN-ODD NUCLEI; FACE; HEAD; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; IODINE ISOTOPES; ISOTOPES; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; NUCLEI; ODD-EVEN NUCLEI; ORGANS; PALLADIUM ISOTOPES; RADIATION DOSE DISTRIBUTIONS; RADIOISOTOPES; RADIOLOGY; SENSE ORGANS; THERAPY |
| Description/Abstract | A dosimetry study compared the use of I-125 vs. Pd-103 radioactive seeds for ophthalmic plaque brachytherapy. Pd-103 seeds in ophthalmic plaques were used to treat 15 patients with intraocular malignant melanoma. Computer-aided simulations were performed to evaluate the intraocular dose distribution of I-125 versus Pd-103 ophthalmic plaques (delivering equivalent apex doses). Seven target points were selected. Starting at the outer scleral surface, four were located along the central axis of the plaque: the 1 mm point (the inner sclera), the 6 mm point, the tumors apex, and the opposite eye wall. They also evaluated the fovea, optic nerve, and the lens because they were considered to be critical structures. These studies demonstrated that the lower energy photons generated by Pd-103 seeds (average 21 KeV) in ophthalmic plaques were more rapidly absorbed in tissue than photons generated by I-125 (average 28 KeV). Therefore, during ophthalmic plaque radiotherapy, Pd-103 photons were found to be more rapidly absorbed within the tumor and less likely to reach most normal ocular structures. On average, the use of Pd-103 decreased the dose to the fovea by 5.7%, to the optic nerve by 8.4%, to the lens by 26%, and to the opposite eye wall by 38.4%. Pd-103 ophthalmic plaque brachytherapy resulted in slightly more irradiation of the tumor and less radiation to most normal ocular structures. 36 refs., 1 fig., 3 tabs. |
| Country of Publication | United States |
| Language | English |
| Format | Medium: X; Size: Pages: 849-854 |
| System Entry Date | 2009 Dec 17 |
Top | |